English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/209050
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease

AuthorsCarvajal, Silvia; Perramón, Meritxell; Oró, Denise; Casals, Eudald ; Fernández-Varo, Guillermo; Casals, Gregori; Parra-Robert, Marina; González de la Presa, Bernardino; Ribera, Jordi; Pastor, Óscar; Morales-Ruiz, Manuel; Puntes, Víctor F. ; Jiménez, Wladimiro
Issue Date2019
PublisherSpringer Nature
CitationScientific Reports 9: 12848 (2019)
AbstractNon-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, ranging from steatosis to non-alcoholic steatohepatitis (NASH). Recently, cerium oxide nanoparticles (CeO2NPs) have emerged as a new antioxidant agent with hepatoprotective properties in experimental liver disease. The aim of the current investigation was to elucidate whether CeO2NPs display beneficial effects in an experimental model of NAFLD.Therefore, fifteen Wistar rats were subjected to a methionine and choline deficient diet (MCDD) for 6 weeks and intravenously treated with CeO2NP or vehicle during the weeks three and four of the diet. The effect of CeO2NPs on serum biochemistry, hepatic steatosis, inflammation, fatty acid content and expression of reactive oxygen species (ROS) and lipid metabolism related genes was assessed. MCDD fed rats showed increased inflammation, enhanced hepatic lipid accumulation of both saturated and unsaturated fatty acids (FAs) and overexpression of genes related to fatty liver and ROS metabolism. Treatment with CeO2NPs was able to reduce the size and content of hepatocyte lipid droplets, the hepatic concentration of triglyceride- and cholesterol ester-derived FAs and the expression of several genes involved in cytokine, adipokine and chemokine signaling pathways. These findings suggest that CeO2NPs could be of beneficial value in NAFLD.
DescriptionSome findings of these studies were previously presented at The International Liver Congress (ILC) 2017 Meeting of the European Association for the Study of the Liver (EASL) (19–23 April, 2017; Amsterdam, The Netherlands).
Publisher version (URL)https://doi.org/10.1038/s41598-019-49262-2
URIhttp://hdl.handle.net/10261/209050
DOI10.1038/s41598-019-49262-2
E-ISSN2045-2322
Appears in Collections:(CIN2) Artículos
Files in This Item:
File Description SizeFormat 
ceriudiseas.pdf2,68 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.